N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (923036-30-0)
Specifications
CAS:
923036-30-0
End Use:
Tofacitinib
M.F.:
C27H31N5O2S
M.W.:
489.64
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
Rhematoid Arthritis Tofacitinib intermediate
,Tofacitinib intermediate 98%
,Tofacitinib intermediate 923036-30-0
Introduction
This compound is mainly used for synthesis of Tofacitinib as intermediate.
| Product Name: | N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
| CAS No.: | 923036-30-0 |
| Assay: | 98% |
| End Use: | Tofacitinib |
| Molecular Formula: | C27H31N5O2S |
| Molecular Weight: | 489.64 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
![]()
![]()
![]()
Related Products
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (477600-74-1)
CAS: 477600-74-1; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
Tofacitinib Citrate (540737-29-9)
CAS: 540737-29-9; tofacitinib manufacturer; tofacitinib vitiligo; alopecia tofacitinib
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (3680-69-1)
CAS: 3680-69-1; Tofacitinib manufacturer; Tofacitinib intermediate; pyrimidine bases
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride (1062580-52-2)
CAS: 1062580-52-2; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
| Image | Part # | Description | |
|---|---|---|---|
|
|
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (477600-74-1) |
CAS: 477600-74-1; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
|
|
|
|
Tofacitinib Citrate (540737-29-9) |
CAS: 540737-29-9; tofacitinib manufacturer; tofacitinib vitiligo; alopecia tofacitinib
|
|
|
|
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (3680-69-1) |
CAS: 3680-69-1; Tofacitinib manufacturer; Tofacitinib intermediate; pyrimidine bases
|
|
|
|
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride (1062580-52-2) |
CAS: 1062580-52-2; Tofacitinib manufacturer; Tofacitinib intermediate; Rhematoid Arthritis
|
Send RFQ
Stock:
In Stock
MOQ:

